BellRing Brands, Inc. (BRBR), the maker of Premier Protein ready-to-drink (RTD) shakes and Dymatize protein powders, has been one of the more volatile consumer staples names of the past two years. BellRing is covered by roughly 15 analysts, with a consensus rating near "Buy" or "Moderate Buy." Individual current targets cluster in a wide band: Barclays at $12, Bernstein and Deutsche Bank at $13, UBS at $9.50, and TD Cowen and Bank of America at $9, alongside J.P. Morgan and D.A. Davidson at $15 and Stifel at $14. The full range runs from about $9 to $20, and the overall average is near $13.35 — essentially at or just below the latest share price.
Because the full mean sits below the current price, a meaningful upside objective requires averaging only the targets above the current level. Those four verifiable targets — roughly $14, $15, $15, and $20 — average to $16, which is the central target used here. Notably, recent revisions have skewed lower: J.P. Morgan cut from $18 to $15, UBS from $14 to $9.50, TD Cowen from $12 to $9, and Bank of America from $10 to $9, while BNP Paribas Exane initiated coverage with an Outperform rating in October. Bulls emphasize discounted valuation and durable brand equity; cautious analysts focus on execution risk in an increasingly crowded protein category. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares traded near $13.58, up more than 20% in a single session after fiscal fourth-quarter results, though still down roughly 62% over the past 12 months. From that level, reaching $16 requires about an 18% advance — a substantial move rather than a trivial one. The path likely hinges on margin recovery. Fiscal fourth-quarter adjusted gross margin fell to 20.1% from 29.7% a year earlier, and fiscal 2027 guidance for $310–$350 million in adjusted EBITDA implies a roughly 14% margin, well below prior peaks. Trailing valuation is compressed at a single-digit P/E, meaning even a partial normalization of profitability could re-rate the stock — but only if execution improves.
BRBR's 52-week range extends from $7.33 to $33.56, leaving the stock in the lower portion of that span after a deep multi-year downtrend from its 2024 peak. The $7.33 low is the key support level, with $10 acting as a psychological floor. On the upside, the $15-to-$20 zone — where several analyst targets cluster — forms near-term resistance, while the 52-week high near $33.56 remains far above current levels.
Analyst price targets generally reflect a roughly 12-month research horizon, and BellRing's wide target range shows that horizon assumptions differ meaningfully between firms. Key items to watch include the next fiscal quarterly report, the trajectory of gross margin and adjusted EBITDA against the fiscal 2027 guidance, category consumption and promotional data, any further analyst target revisions, and developments in tariffs and input costs that directly affect the cost base. From what I see, monitoring these elements will be essential to gauge whether the stock can sustain momentum.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like BRBR, this kind of automated, always-on surveillance can help traders spot shifting trends, discover new opportunities, and monitor existing positions more efficiently than manual screening alone. I find it useful to review these signals regularly as conditions evolve for names facing margin and competitive pressures.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BRBR moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend. In 29 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 76%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on BRBR as a result. In 60 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The 10-day moving average for BRBR crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +5.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBR advanced for three days, in 204 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.
The Aroon Indicator entered an Uptrend today. In 171 of 225 cases where BRBR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 76%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
BRBR broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.280) is normal, around the industry mean (6.914). P/E Ratio (6.406) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (1.340) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.462) is also within normal values, averaging (5.003).
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. BRBR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified